UK bank shares: not for widows or orphans

No-one earning their bonuses right now.

The half yearly reporting season for UK-headquartered banks is almost upon us.

Following nine years of record profits, UK-based but Asia-Pac focused Standard Chartered is likely once again to be the strongest sector performer. It reports on 1st August and no major surprises are expected. StanChart’s shares remain the strongest performer of the UK banks; as of this morning, StanChart’s share price has fallen by a mere 10.8 per cent in the past 12 months.

The day before on 30 July, HSBC reports its first half profits. Notwithstanding all the understandable hullabaloo over its extensive anti-money laundering failures, the market is likely to be in forgiving mood. HSBC’s share price, in the past 12 months, is down a relatively modest 14 per cent.

The reporting season kicks off with Lloyds Banking Group (LBG) on Thursday. Expect to hear positive noises about profits growth in 2013 and earnings being boosted in 2014 as a result of the Project Verde sell off having been scaled down in terms of assets sold. LBG’s share price, by the by, is down a whopping 35.6 per cent in the past 12 months.

Barclays will report on Friday and will attract a great deal of attention, following its role in the LIBOR scandal and the departure of Bob Diamond. It may even report an increase in underlying profits of up to 10 per cent year-on-year in the six months to end June. The plunging share price of Barclays seems to have played little more than a peripheral role when it has come to determining bonuses at Barclays. In the past year alone, the Barclays’ share price is down by a whopping 33.6 per cent.

Bringing up the rear, in more ways than one (share price down by 45.4 per cent in the last 12 months), Royal Bank of Scotland reports on 3 August. RBS continues to hemorrhage money in Ireland via its Ulster Bank operation. It remains very hard to foresee RBS returning to profit in 2012. The IT shambles earlier in the summer plus media rumours of an involvement in the LIBOR scandal, means that good news relating to RBS is some way off. There will be analysts that suggest that RBS’ share price has now sunk so low  - down from £3.63 to £1.98 in the past year - that it represents an attractive punt.  That may well be the case: but it is not one for widows or orphans.

Just in case any of the UK banks dare to suggest that a collapse in bank share prices is a disease afflicting banks around the world and that they really are earning their bonuses, don’t believe them.

Two of the largest US-based banks – US Bancorp and Wells Fargo – have enjoyed strong double-digit share price growth in the past year; Westpac and National Australia Bank have also shown a rise in their share price while Canada’s largest lender, Royal Bank of Canada’s share price is flat.

Meantime, the results have been released today of the latest UK Customer Satisfaction Index (UKCSI) by the Institute of Customer Service. 

In the banking sector, the UKCSI shows – yet again – that first direct ranks top. With a certain degree of predictability, the Coop Bank ranks second.

The survey will really deserve a greater degree of comment if and when first direct and the coop do not come out at the top of the poll of 26,000 customers.

For the record, Yorkshire Bank ranked third, just ahead of Nationwide and HSBC in fourth and fifth places respectively.

London at night, Photograph:Getty Images.

Douglas Blakey is the editor of Retail Banker International

Getty Images.
Show Hide image

Is anyone prepared to solve the NHS funding crisis?

As long as the political taboo on raising taxes endures, the service will be in financial peril. 

It has long been clear that the NHS is in financial ill-health. But today's figures, conveniently delayed until after the Conservative conference, are still stunningly bad. The service ran a deficit of £930m between April and June (greater than the £820m recorded for the whole of the 2014/15 financial year) and is on course for a shortfall of at least £2bn this year - its worst position for a generation. 

Though often described as having been shielded from austerity, owing to its ring-fenced budget, the NHS is enduring the toughest spending settlement in its history. Since 1950, health spending has grown at an average annual rate of 4 per cent, but over the last parliament it rose by just 0.5 per cent. An ageing population, rising treatment costs and the social care crisis all mean that the NHS has to run merely to stand still. The Tories have pledged to provide £10bn more for the service but this still leaves £20bn of efficiency savings required. 

Speculation is now turning to whether George Osborne will provide an emergency injection of funds in the Autumn Statement on 25 November. But the long-term question is whether anyone is prepared to offer a sustainable solution to the crisis. Health experts argue that only a rise in general taxation (income tax, VAT, national insurance), patient charges or a hypothecated "health tax" will secure the future of a universal, high-quality service. But the political taboo against increasing taxes on all but the richest means no politician has ventured into this territory. Shadow health secretary Heidi Alexander has today called for the government to "find money urgently to get through the coming winter months". But the bigger question is whether, under Jeremy Corbyn, Labour is prepared to go beyond sticking-plaster solutions. 

George Eaton is political editor of the New Statesman.